We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO
Marathon Oil Corporation
MRO
+$123M
5
CHX
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS
Discover Financial Services
DFS
+$45.1M
4
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Materials 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDGR icon
451
CALL
Schrodinger
SDGR
$1.33B
$33.5K ﹤0.01%
+70,000
New +$1.61M
BMRN icon
452
CALL
BioMarin Pharmaceuticals
BMRN
$12.1B
$33K ﹤0.01%
40,000
+15,000
+60% +$1.25M
ALNY icon
453
PUT
Alnylam Pharmaceuticals
ALNY
$28.6B
$27.9K ﹤0.01%
+19,100
New +$3.02M
XAGEW
454
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$27.1K ﹤0.01%
371,250
– –
INSP icon
455
CALL
Inspire Medical Systems
INSP
$1.73B
$26.1K ﹤0.01%
+12,000
New +$2.27M
NAVI icon
456
PUT
Navient
NAVI
$821M
$26K ﹤0.01%
16,500
– –
AGIO icon
457
CALL
Agios Pharmaceuticals
AGIO
$1.9B
$25.9K ﹤0.01%
45,000
+5,000
+13% +$180K
DXCM icon
458
PUT
DexCom
DXCM
$31.6B
$25.9K ﹤0.01%
+15,000
New +$1.9M
CRSP icon
459
PUT
CRISPR Therapeutics
CRSP
$5.17B
$25.5K ﹤0.01%
15,000
-5,000
-25% -$289K
QURE icon
460
CALL
uniQure
QURE
$3.2B
$24K ﹤0.01%
+80,000
New +$390K
SWTX
461
CALL
DELISTED
SpringWorks Therapeutics
SWTX
$24K ﹤0.01%
+20,000
New +$842K
XLV icon
462
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.5B
$23.4K ﹤0.01%
45,000
-35,000
-44% -$5.02M
APLS
463
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$23.1K ﹤0.01%
+12,500
New +$566K
SNY icon
464
CALL
Sanofi
SNY
$105B
$22.5K ﹤0.01%
+30,000
New +$1.45M
JNJ icon
465
PUT
Johnson & Johnson
JNJ
$619B
$19.9K ﹤0.01%
+17,500
New +$2.6M
BSLKW
466
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$19.8K ﹤0.01%
114,498
– –
AM icon
467
PUT
Antero Midstream
AM
$10.2B
$19.2K ﹤0.01%
95,800
– –
IWM icon
468
PUT
iShares Russell 2000 ETF
IWM
$82.8B
$18.9K ﹤0.01%
+180,000
New +$36.4M
PETQ
469
PUT
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$18.8K ﹤0.01%
50,000
– –
BAX icon
470
CALL
Baxter International
BAX
$14.1B
$18K ﹤0.01%
+90,000
New +$3.32M
MRNA icon
471
CALL
Moderna
MRNA
$22.5B
$17.9K ﹤0.01%
16,000
-4,000
-20% -$506K
CYTK icon
472
CALL
Cytokinetics
CYTK
$10.4B
$17.8K ﹤0.01%
+23,000
New +$1.39M
APXIW
473
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$17.4K ﹤0.01%
91,439
– –
JWSM.WS
474
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$16.4K ﹤0.01%
172,581
– –
MNTN.WS
475
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$15.6K ﹤0.01%
78,716
– –
17 18
19
20 21

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.